FDA Inspection 1296662 — Infusyn Therapeutics
The FDA completed an inspection of Infusyn Therapeutics on Nov 20, 2025 in Hackettstown, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 20, 2025
- Fiscal Year
- 2026
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Hackettstown, NJ (United States)